FDA approves testing CBD for use in opioid addiction treatment

Earlier this month, FDA gave the green light for human testing of CBD for opioid addiction treatment, a step further for the industry. Since part of addiction treatment is the reduction of craving, CBD will be tested in its ability to lessen the craving [...]

CBD pricing steady month on month

As of Oct. 21, average U.S. CBD isolate pricing was steady month on month, remaining 3 percent below prices seen in early August and 13 percent below the calendar-year high in January. To better understand public health issues around CBD and other cannabinoids, FDA [...]

CBD pricing weakens slightly month on month

As of Sep. 15, average U.S. CBD isolate pricing is down over 3 percent since the beginning of August and down nearly 7 percent vs. this time a year ago. Despite the recent decline in pricing, the U.S. industry is still anticipating steady-to-quick demand [...]

CBD pricing stabilizes as hemp planting presses on

The average price of CBD isolate in the U.S remained steady throughout May and was up just 2 percent from lows seen in February 2021. In the U.S., documented acreage licensed for production is down 44 percent YOY as growers are opting to plant [...]

CBD isolate pricing down from January highs

As of Mar. 15, average daily U.S. CBD isolate prices were down nearly 6 percent from the early-January highs, but up almost 6 percent from last October’s all-time lows. Sales of hemp CBD products fell 2 percent in 2020 to about $803 million, but [...]

CBD isolate pricing rises despite drop in sales

As of Dec. 21, average daily U.S. CBD isolate prices were at a five-month high and almost 10 percent higher than they were in October. U.S. sales of food and beverage products containing CBD or hemp were down 75 percent YOY as of early-December, [...]

Go to Top